SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer concludes acquisition of Hospira

05 Sep 2015 Evaluate

Pfizer has completed its acquisition of Hospira, Inc. on September 03, 2015, creating a leading Global Established Pharmaceutical (GEP) Business. Hospira is the world’s leading provider of injectable drugs and infusion technologies and a global leader in biosimilars.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.


Pfizer Share Price

4794.05 -17.00 (-0.35%)
11-May-2026 09:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.45
Dr. Reddys Lab 1275.00
Cipla 1333.20
Zydus Lifesciences 932.75
Lupin 2237.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×